Limfa Machine Therapy ®

   Osteoporosis so far these are the outcomes:

Limfa to bisphosphonates (Denosumab) comparison:

LIMFA TREATMENT RESULTS:

• 167% increase in type 2 collagen formation. 1800% increase in RUNX2 transcription factor.
• (Scientifically significant is only a 5% change)

 FACTS:

Fibromyalgia has a worldwide presence affecting nearly 1 in 20 people globally. In the United States nearly 2–10% of the general population of all ages are affected by this condition – over 5M people. Women have a far higher rate of Fibromyalgia than men.

 LIMFA TREATMENT RESULTS:

• 67% reduction in pain & functionality score related to the Fibromyalgia Impact Questionnaire.
• 63% reduction in pain & functionality score

 NOTE: There is currently NO treatment for Fibromyalgia other than pharmaceutical drugs. Limfa’s research and efficacy is positioned to dramatically impact the healthcare field for this condition.

FACTS:

Osteoarthritis affects over 32.5 million US adults. 14 million people have knee osteoarthritis problems. Worldwide, an estimated 500 million people have osteoarthritis. Cases of osteoarthritis increased globally by 113% in 3 decades.

LIMFA TREATMENT RESULTS:

• 54% increase in mobility
• 67% reduction in pain (VAS)
• 85% improved patient satisfaction

NOTE: There is currently NO treatment for Osteoarthritis other than pharmaceutical drugs.  Stem cell therapy, and PRP (which work well for some but not for others).

FACTS:
CTS affects approximately 3 to 6 percent of adults in the general population. According to the Rheumatology Research Foundation, CTS impacts 4 to 10 million Americans.

LIMFA TREATMENT RESULTS:

• 40% decrease in pain (VAS)
• 1 month of treatment.
• 95% decrease in pain (VAS)
• 3 months of treatment.

 NOTE: There is currently NO treatment for CTS other than pharmaceutical drugs, NSAIDs, injections, immobilization, or surgery. Limfa’s research and efficacy is positioned to dramatically impact the healthcare field for this condition.

Approximately 6.3 million fractures occur each year in the U.S. Globally, 310 million major surgeries are performed each year, with around 40 to 50 million in USA and 20 million in Europe.

LIMFA TREATMENT RESULTS:

90% increase in bone consolidation after 1 month.
Bone healing delay occurs in 10% of fracture cases (as well as pseudoarthrosis during spinal fusion).
Limfa found resolution with only 1 month of therapy at a 90% success rate.
Bones were totally healed after 3 months.
Treatment was 3 treatments per week for 4 to 5 weeks.

Future studies are planned for the following industries and health conditions:

• Sleep
• Anti-Aging / Longevity
• Bed Sores
• Immune Function
• Plantar fasciitis
• Cancer Prevention &
• Cancer Treatment
• Erectile Dysfunction
• Prostate
• Sports Medicine
• Post-workout recovery
• Diabetic neuropathy
• Vaginal Rejuvenation
• Neck & back pain
• Headaches
• Concussions